Orotate phosphoribosyltransferase

Orotate Phosphoribosyltransferase (OPRT) is an enzyme that plays a crucial role in the pyrimidine biosynthesis pathway, which is essential for the synthesis of nucleotides. Nucleotides are the building blocks of DNA and RNA, making OPRT vital for cellular growth, division, and the maintenance of genetic information. This enzyme catalyzes the conversion of orotic acid (orotate) and 5-phosphoribosyl-1-pyrophosphate (PRPP) into orotidine-5'-monophosphate (OMP) and pyrophosphate, a key step in the pyrimidine biosynthesis pathway.

Function

The primary function of orotate phosphoribosyltransferase is to facilitate the synthesis of pyrimidine nucleotides from orotic acid. This process is critical for the production of cytosine, thymine, and uracil, which are essential components of DNA and RNA. By converting orotate to OMP, OPRT plays a pivotal role in ensuring that cells have a sufficient supply of nucleotides for replication and transcription.

Genetics

The gene encoding orotate phosphoribosyltransferase varies among different organisms. In humans, the UMPS (Uridine Monophosphate Synthetase) gene encodes a bifunctional enzyme that includes both OPRT and Orotidine 5'-phosphate decarboxylase activities, essential for the de novo synthesis of pyrimidine nucleotides.

Clinical Significance

Alterations in the activity of OPRT can have significant clinical implications. For example, reduced activity of this enzyme can lead to orotic aciduria, a rare metabolic disorder characterized by the excretion of large amounts of orotic acid in urine. This condition can lead to physical and mental retardation if not diagnosed and treated early. Furthermore, the activity of OPRT is also a factor in the efficacy and toxicity of certain chemotherapeutic agents, such as 5-fluorouracil, which are used in the treatment of cancer.

Pharmacology

In the context of pharmacology, OPRT is a target for certain chemotherapeutic agents. The enzyme's role in nucleotide biosynthesis makes it a potential target for drugs designed to inhibit DNA and RNA synthesis in rapidly dividing cells, including cancer cells. Understanding the activity and regulation of OPRT can lead to the development of more effective and less toxic therapeutic agents.

See Also

• Pyrimidine biosynthesis
• Nucleotide
• DNA
• RNA
• UMPS
• Orotidine 5'-phosphate decarboxylase
• Orotic aciduria

Orotate phosphoribosyltransferase Resources
Latest articles Most recent articles Ongoing trials	Wikipedia